Among the companies with shares expected to trade actively in
Monday's session are Novo Nordisk A/S (NVO, NOVO-B.KO), US Airways
Group Inc. (LCC) and Radian Group Inc. (RDN).
Novo Nordisk said U.S. regulators have asked for additional
testing on its hotly anticipated Tresiba insulin products, which
could lead to a delay of the drug's launch in a key market. The
U.S. Food and Drug Administration asked for additional
cardiovascular data. The Danish company, which is the world's
largest maker of insulin, said it doesn't expect to be able to
provide the information during 2013. American depositary shares
fell 14% to $165.65 premarket.
As AMR Corp.'s (AAMRQ) American Airlines and US Airways
intensify their talks on a possible merge that could be announced
in the coming days, US Airways pilots on Friday widely approved a
provisional labor agreement that would help smooth the path toward
a combination, their union said. Plus, according to The Wall Street
Journal, experts have said that the potential deal would likely fly
clear of government objections. U.S. Airways shares rose 1.7% to
$15 premarket.
Radian Group's fourth-quarter loss widened as the year-earlier
period included higher gains related to the fair value of
derivatives and other impacts. Companies such as Radian Guaranty
typically insure mortgages when a borrower makes a down payment of
less than 20%. The loss was wider than expected and net premiums
earned were lower than analyst estimates. Shares fell 5.5% to $6.35
premarket.
Celegene Corp. (CELG) said Chinese regulators approved Revlimid
for relapsed or refractory multiple melanoma, while the U.S. Food
and Drug Administration granted priority review status to the
flagship blood-cancer treatment for patients with a rare blood
cancer known as mantle-cell lymphoma. The biopharmaceutical
company's shares rose 1.9% to $102 premarket.
Harvest Natural Resources Inc. (HNR) announced another oil
discovery in the presalt offshore Gabon, West Africa. Shares of the
independent oil-and-gas exploration and development company rose
4.9% to $9.50 premarket.
American Capital Mortgage Investment Corp. (MTGE), a real estate
investment trust, reported that fourth-quarter per-share earnings
came in slightly above analysts' estimates. "We prepared for the
possibility of QE3 and positioned the portfolio appropriately,
allocating more capital to assets less affected by QE3, with more
upside to a potential housing recovery," said Chief Executive Malon
Wilkus. Shares rose 3.9% to $26.45 in premarket trading.
Watchlist:
Boardwalk Pipeline Partners L.P.'s (BWP) fourth-quarter earnings
rose 26% as the oil-and-gas transporter recorded strong revenue
growth across all its segments.
Brookfield Asset Management Inc. (BAM) has agreed to buy 19
apartment communities for $414 million from Babcock & Brown
Residential, as the alternative-asset manager aims to expand its
multi-family platform.
Constellation Brands Inc. (STZ) filed a motion to intervene in
the Department of Justice's lawsuit to block Anheuser-Busch InBev
SA/NV's (BUD, ABI.BT) $20.1 billion bid to buy Grupo Modelo SA
(GMODELO.MX), as the wine and spirits maker is set to expand as
part of a side deal in the proposed merger. Anheuser-Busch InBev
also came out in support of the motion.
Gulfport Energy Corp. (GPOR) agreed to acquire another 22,000
net acres in the Utica Shale in eastern Ohio from Windsor Ohio LLC
for about $220 million as the oil-and-natural-gas producer
continues to boost its presence in the shale basin.
Lowes Corp. (L) swung to a fourth-quarter loss as its CNA
Financial Corp. (CNA) insurance unit was hit by losses related to
Hurricane Sandy, and because of a large impairment charge at
HighMount Exploration & Production LLC.
Write to Anna Prior at anna.prior@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires